HDAC9 is an epigenetic repressor of kidney angiotensinogen establishing a sex difference

Abstract

BackgroundSexual difference has been shown in the pathogenesis of chronic kidney disease induced by hypertension. Females are protected from hypertension and related end-organ damage. Augmentation of renal proximal tubular angiotensinogen (AGT) expression can promote intrarenal angiotensin formation and the development of associated hypertension and kidney injury. Female rodents exhibit lower intrarenal AGT levels than males under normal conditions, suggesting that the suppressed intrarenal AGT production by programmed mechanisms in females may provide protection from these diseases. This study was performed to examine whether epigenetic mechanisms serve as repressors of AGT.MethodsMale and female Sprague Dawley rats were used to investigate sex differences of systemic, hepatic, and intrarenal AGT levels. All histone deacetylase (HDAC) mRNA levels in the kidneys were determined using a PCR array. HDAC9 protein expression in the kidneys and cultured renal proximal tubular cells (PTC) was analyzed by Western blot analysis and immunohistochemistry. The effects of HDAC9 on AGT expression were evaluated by using an inhibitor and siRNA. ChIP assay was performed to investigate the interaction between the AGT promoter and HDAC9.ResultsPlasma and liver AGT levels did not show differences between male and female Sprague-Dawley rats. In contrast, females exhibited lower AGT levels than males in the renal cortex and urine. In the absence of supplemented sex hormones, primary cultured renal cortical cells isolated from female rats sustained lower AGT levels than those from males, suggesting that the kidneys have a unique mechanism of AGT regulation controlled by epigenetic factors rather than sex hormones. HDAC9 mRNA and protein levels were higher in the renal cortex of female rats versus male rats (7.09 ± 0.88, ratio to male) while other HDACs did not exhibit a sex difference. HDAC9 expression was localized in PTC which are the primary source of intrarenal AGT. Importantly, HDAC9 knockdown augmented AGT mRNA (1.92 ± 0.35-fold) and protein (2.25 ± 0.50-fold) levels, similar to an HDAC9 inhibitor. Furthermore, an interaction between HDAC9 and a distal 5’ flanking region of AGT via a histone complex containing H3 and H4 was demonstrated.ConclusionsThese results indicate that HDAC9 is a novel suppressing factor involved in AGT regulation in PTC, leading to low levels of intrarenal AGT in females. These findings will help to delineate mechanisms underlying sex differences in the development of hypertension and renin-angiotensin system (RAS) associated kidney injury.

Single cell RNA sequencing reveals C5aR1 inhibition to selectively target pro-tumorigenic M2 macrophages reversing PARP inhibitor resistance

“…Using RNA velocity trajectory analysis, transcriptomic pro ling and ChIP-PCR, we have implicated MEF2C along with its co-repressor HDAC9 in suppressing C5aR1 expression. MEF2C has previously been implicated in repressing M2 macrophage function while promoting M1 macrophage polarization [39,74]. This is consistent with our trajectory analysis that implicates C5aR1 in the transition to a M2 phenotype.…”

Transcriptome analysis of genes related to gonad differentiation and development in Muscovy ducks

“…Herein, AGT was involved in fertilization and the acrosome reaction process. In the kidney cortex, AGT gene expression was higher in males than females [40,41]. Moreover, both SRY and SRY-box transcription factor 3 (SOX3) upregulated the promoter of AGT [42].…”

The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury

“…Previous studies have shown that there are sex-specific HDAC expression differences in brain regions ( Gilbert et al, 2019) , and sexually dimorphic expression of HDACs could be relevant to the higher prevalence of neuropsychiatric disorders and neurodegenerative diseases in females. In the kidney, HDAC9 mRNA and protein levels in the renal cortex of female rats were higher than those of male rats, while other HDAC levels did not differ by sex; HDAC9 is a novel inhibitor of augmentation of renal proximal tubular angiotensinogen (AGT) regulation, leading to low levels of AGT in the kidneys of women, protecting females from hypertension and related end-organ damage ( Bourgeois et al, 2017 ). These studies all suggest that there are differences in HDAC expression in different genders, which may affect the disease incidence.…”